Nimish Shah

Partner

2013 - Current

Co-Founder and Board Director

2021

Research Analyst

2010 - 2013

Healthcare analyst for Surveyor Capital, a market neutral equity fund part of the Citadel Investment Group.

Research Analyst

2007 - 2010

Equity Research - Coverage included specialty and generic pharmaceutical companies. Assumed primary coverage of generics sector prior to departure.

Senior Consultant

2006 - 2007

Developed and/or refined commercial strategies for global top 20 pharmaceutical and biotechnology companies.

Outcomes Research Intern

2004 - 2005

Conducted outcomes and health economic analysis to support the commercialization of $500mm - $1bn CNS product.

Medical Information Associate

2002 - 2003

Supported commercialization of Novartis products by providing medical information to key opinion leaders.